Gian Life Care Valuation

Q: What is the Fair Price of 542918 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

542918 (₹18.99) is trading above our estimate of [[fair value]] (₹6.21)

Is 542918 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 542918 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 542918 (₹18.99) is trading above our estimate of fair value (₹6.21)

Significantly Below Fair Value: 542918 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 542918?

Key metric: As 542918 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 542918. This is calculated by dividing 542918's market cap by their current earnings.
What is 542918's PE Ratio?
PE Ratio	5x
Earnings	₹38.96m
Market Cap	₹196.39m

542918 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.1x
Enterprise Value/EBITDA	4.5x
PEG Ratio	n/a

Price to Earnings Ratio vs Peers

How does 542918's PE Ratio compare to its peers?

The above table shows the PE ratio for 542918 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	34.2x
544220 Clinitech Laboratory	33.5x	n/a	₹175.7m
526301 Medinova Diagnostic Services	20.8x	n/a	₹400.2m
541299 Dr Lalchandani Labs	8.7x	n/a	₹74.3m
530697 Zenlabs Ethica	73.7x	n/a	₹265.5m
542918 Gian Life Care	5x	n/a	₹196.4m

Price-To-Earnings vs Peers: 542918 is good value based on its Price-To-Earnings Ratio (5x) compared to the peer average (34.2x).

Price to Earnings Ratio vs Industry

How does 542918's PE Ratio compare vs other companies in the IN Healthcare Industry?

1 Company	Price / Earnings	Estimated Growth	Market Cap
523696 Fortis Malar Hospitals	2.4x	n/a	US$13.57m

No more companies available in this PE range

1 Company		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 542918 is good value based on its Price-To-Earnings Ratio (5x) compared to the Indian Healthcare industry average (45.5x).

Price to Earnings Ratio vs Fair Ratio

What is 542918's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

542918 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	5x
Fair PE Ratio	n/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 542918's Price-To-Earnings Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.